Search hospitals > Oregon > Portland
Providence Cancer Center at Providence Portland Medical Center
Claim this profilePortland, Oregon 97213
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Solid Tumors
Conducts research for Pancreatic Cancer
Conducts research for Cancer
165 reported clinical trials
9 medical researchers
Summary
Providence Cancer Center at Providence Portland Medical Center is a medical facility located in Portland, Oregon. This center is recognized for care of Breast Cancer, Lung Cancer, Solid Tumors, Pancreatic Cancer, Cancer and other specialties. Providence Cancer Center at Providence Portland Medical Center is involved with conducting 165 clinical trials across 253 conditions. There are 9 research doctors associated with this hospital, such as Rachel Sanborn, MD, Matthew Taylor, MD, Rom S. Leidner, MD, and Brendan D. Curti, MD.Area of expertise
1Breast Cancer
Global LeaderStage IV
Stage III
HER2 positive
2Lung Cancer
Global LeaderStage IV
Stage III
PD-L1 positive
Top PIs
Rachel Sanborn, MDProvidence Portland Medical Center6 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
43 reported clinical trials
68 drugs studied
Matthew Taylor, MDProvidence Portland Medical Center5 years of reported clinical research
Studies Melanoma
Studies Non-Small Cell Lung Cancer
20 reported clinical trials
36 drugs studied
Rom S. Leidner, MDProvidence Cancer Institute Franz Clinic6 years of reported clinical research
Studies Head and Neck Cancers
Studies Squamous Cell Carcinoma
15 reported clinical trials
32 drugs studied
Brendan D. Curti, MDProvidence Portland Medical Center1 year of reported clinical research
Studies Melanoma
Studies Cancer
14 reported clinical trials
26 drugs studied
Clinical Trials running at Providence Cancer Center at Providence Portland Medical Center
Breast Cancer
Lung Cancer
Ovarian Cancer
Cancer
Solid Tumors
Non-Hodgkin's Lymphoma
Colorectal Cancer
Squamous Cell Carcinoma
Non-Small Cell Lung Cancer
Pancreatic Cancer
PF-07220060 + Letrozole
for Breast Cancer
The purpose of this study is to determine the safety and efficacy of PF-07220060 with letrozole compared to approved treatments (ie, palbociclib, ribociclib or abemaciclib with letrozole) in people with breast cancer: * HR-positive (breast cancer cells that need estrogen or progesterone to grow) * HER2-negative (cells that have a small amount or none of a protein called HER2 on their surface); * locally advanced (that has spread from where it started to nearby tissue or lymph nodes) or metastatic disease (the spread of cancer to other places in the body) * who have not received any prior systemic anti-cancer treatment for advanced/metastatic disease. Approximately half of the participants will receive PF-07220060 plus letrozole while the other half of participants will receive the investigator's choice of treatment plus letrozole. The study team will monitor how each participant is doing with the study treatment during regular visits at the study clinic.
Recruiting2 awards Phase 34 criteria
SGN-B6A
for Cancer
This trial is testing a new drug called sigvotatug vedotin alone and with other treatments to see if it is safe and effective for people with solid tumors. It will also check for any side effects. The study includes different parts to determine the best dose and to see how well the drug works alone and in combination with other treatments.
Recruiting1 award Phase 1
STX-478 + Fulvestrant
for Advanced Breast Cancer
This trial is testing a new drug called STX-478 to see if it can help treat advanced solid tumors and breast cancer. The study will look at how safe the drug is, how it behaves in the body, and if it can stop or slow down cancer growth. Some patients will receive just STX-478, while others will get it combined with another drug called fulvestrant, which is often used to treat advanced breast cancer.
Recruiting1 award Phase 1 & 25 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Providence Cancer Center at Providence Portland Medical Center?
Providence Cancer Center at Providence Portland Medical Center is a medical facility located in Portland, Oregon. This center is recognized for care of Breast Cancer, Lung Cancer, Solid Tumors, Pancreatic Cancer, Cancer and other specialties. Providence Cancer Center at Providence Portland Medical Center is involved with conducting 165 clinical trials across 253 conditions. There are 9 research doctors associated with this hospital, such as Rachel Sanborn, MD, Matthew Taylor, MD, Rom S. Leidner, MD, and Brendan D. Curti, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.